Читать книгу Surgical Management of Advanced Pelvic Cancer - Группа авторов - Страница 40

1 1 de Wilt, J.H., Vermaas, M., Ferenschild, F.T., and Verhoef, C. (2007). Management of locally advanced primary and recurrent rectal cancer. Clin. Colon Rectal Surg. 20: 255–263.

2 2 Warrier, S.K., Heriot, A.G., and Lynch, A.C. (2016). Surgery for locally recurrent rectal cancer: tips, tricks, and pitfalls. Clin. Colon Rectal Surg. 29: 114–122.

3 3 Harji, D.P., Griffiths, B., McArthur, D.R., and Sagar, P.M. (2012). Current UK management of locally recurrent rectal cancer. Color. Dis. 14: 1479–1482.

4 4 Helewa, R.M. and Park, J. (2016). Surgery for locally advanced T4 rectal cancer: strategies and techniques. Clin. Colon Rectal Surg. 29: 106–113.

5 5 Brunschwig, A. (1948). Complete excision of pelvic viscera for advanced carcinoma; a one‐stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1: 177–183.

6 6 Shaikh, I., Holloway, I., Aston, W. et al. (2016). High subcortical sacrectomy: a novel approach to facilitate complete resection of locally advanced and recurrent rectal cancer with high (S1–S2) sacral extension. Color. Dis. 18: 386–392.

7 7 Milne, T., Solomon, M.J., Lee, P. et al. (2013). Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann. Surg. 258: 1007–1013.

8 8 Melton, G.B., Paty, P.B., Boland, P.J. et al. (2006). Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis. Colon Rectum 49: 1099–1107.

9 9 Shaikh, I., Aston, W., Hellawell, G. et al. (2014). Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall. Tech. Coloproctol. 18: 1161–1168.

10 10 Shaikh, I.A. and Jenkins, J.T. (2017). Extended pelvic side wall excision for locally advanced rectal cancers. World J. Gastroenterol. 23: 8261–8262.

11 11 Solomon, M.J., Brown, K.G., Koh, C.E. et al. (2015). Lateral pelvic compartment excision during pelvic exenteration. Br. J. Surg. 102: 1710–1717.

12 12 Austin, K.K. and Solomon, M.J. (2009). Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Dis. Colon Rectum 52: 1223–1233.

13 13 Hockel, M. (2015). Long‐term experience with (laterally) extended endopelvic resection (LEER) in relapsed pelvic malignancies. Curr. Oncol. Rep. 17: 435.

14 14 Hockel, M. (2008). Laterally extended endopelvic resection (LEER) – principles and practice. Gynecol. Oncol. 111: S13–S17.

15 15 Solomon, M.J., Austin, K.K., Masya, L., and Lee, P. (2015). Pubic bone excision and perineal urethrectomy for radical anterior compartment excision during pelvic exenteration. Dis. Colon Rectum 58: 1114–1119.

16 16 Mehta, A.M., Hellawell, G., Burling, D. et al. (2018). Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes. Tech. Coloproctol. 22: 663–671.

17 17 Bhangu, A., Ali, S.M., Brown, G. et al. (2014). Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann. Surg. 259: 315–322.

18 18 Heriot, A.G., Byrne, C.M., Lee, P. et al. (2008). Extended radical resection: the choice for locally recurrent rectal cancer. Dis. Colon Rectum 51: 284–291.

19 19 Hansen, M.H., Balteskard, L., Dorum, L.M. et al. (2009). Locally recurrent rectal cancer in Norway. Br. J. Surg. 96: 1176–1182.

20 20 Nielsen, M.B., Rasmussen, P.C., Lindegaard, J.C., and Laurberg, S. (2012). A 10‐year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Color. Dis. 14: 1076–1083.

21 21 Bhangu, A., Ali, S.M., Darzi, A. et al. (2012). Meta‐analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Color. Dis. 14: 1457–1466.

22 22 PelvEx Collaborative (2019). Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann. Surg. 269 (2): 315–321.

23 23 PelvEx Collaborative (2018). Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. Br. J. Surg. 105: 650–657.

24 24 Georgiou, P.A., Tekkis, P.P., and Brown, G. (2011). Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options. Cancer Imaging 11: S103–S111.

25 25 Peschaud, F., Cuenod, C.A., Benoist, S. et al. (2005). Accuracy of magnetic resonance imaging in rectal cancer depends on location of the tumor. Dis. Colon Rectum 48: 1603–1609.

26 26 Kim, Y.W., Cha, S.W., Pyo, J. et al. (2009). Factors related to preoperative assessment of the circumferential resection margin and the extent of mesorectal invasion by magnetic resonance imaging in rectal cancer: a prospective comparison study. World J. Surg. 33: 1952–1960.

27 27 Granero‐Castro, P., Munoz, E., Frasson, M. et al. (2014). Evaluation of mesorectal fascia in mid and low anterior rectal cancer using endorectal ultrasound is feasible and reliable: a comparison with MRI findings. Dis. Colon Rectum 57: 709–714.

28 28 Phang, P.T., Gollub, M.J., Loh, B.D. et al. (2012). Accuracy of endorectal ultrasound for measurement of the closest predicted radial mesorectal margin for rectal cancer. Dis. Colon Rectum 55: 59–64.

29 29 Shur, J., Corr, A., Burling, D., and Jenkins, J.T. (2018). SS 2.9 Endorectal ultrasound is accurate for the assessment of anterior resection margin in low rectal cancer. Insights Imaging 9: S663.

30 30 Marusch, F., Ptok, H., Sahm, M. et al. (2011). Endorectal ultrasound in rectal carcinoma – do the literature results really correspond to the realities of routine clinical care? Endoscopy 43: 425–431.

31 31 Balyasnikova, S. and Brown, G. (2016). Optimal imaging strategies for rectal cancer staging and ongoing management. Curr. Treat. Options Oncol. 17: 32.

32 32 von Schulthess, G.K., Steinert, H.C., and Hany, T.F. (2006). Integrated PET/CT: current applications and future directions. Radiology 238: 405–422.

33 33 Suzuki, K., Dozois, R.R., Devine, R.M. et al. (1996). Curative reoperations for locally recurrent rectal cancer. Dis. Colon Rectum 39: 730–736.

34 34 Yamada, K., Ishizawa, T., Niwa, K. et al. (2001). Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br. J. Surg. 88: 988–993.

35 35 Wanebo, H.J., Antoniuk, P., Koness, R.J. et al. (1999). Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis. Colon Rectum 42: 1438–1448.

36 36 Moore, H.G., Shoup, M., Riedel, E. et al. (2004). Colorectal cancer pelvic recurrences: determinants of resectability. Dis. Colon Rectum 47: 1599–1606.

37 37 Georgiou, P.A., Tekkis, P.P., Constantinides, V.A. et al. (2013). Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. Eur. J. Cancer 49: 72–81.

38 38 Kim, Y.H., Kim, D.Y., Kim, T.H. et al. (2005). Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 62: 761–768.

39 39 Hartley, A., Ho, K.F., McConkey, C., and Geh, J.I. (2005). Pathological complete response following pre‐operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br. J. Radiol. 78: 934–938.

40 40 Rullier, E. and Sebag‐Montefiore, D. (2006). Sphincter saving is the primary objective for local treatment of cancer of the lower rectum. Lancet Oncol. 7: 775–777.

41 41 Ryan, J.E., Warrier, S.K., Lynch, A.C., and Heriot, A.G. (2015). Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Color. Dis. 17: 849–861.

42 42 Hoffmann, K.‐T., Rau, B., Wust, P. et al. (2002). Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio‐chemotherapy plus regional hyperthermia. Strahlenther. Onkol. 178: 386–392.

43 43 Beyond TME Collaborative (2013). Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br. J. Surg. 100: 1009–1014.

44 44 Barbaro, B., Vitale, R., Leccisotti, L. et al. (2010). Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 30: 699–716.

45 45 Dresen, R.C., Beets, G.L., Rutten, H.J. et al. (2009). Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 252: 71–80.

46 46 Barbaro, B., Fiorucci, C., Tebala, C. et al. (2009). Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 250: 730–739.

47 47 Jhaveri, K.S. and Hosseini‐Nik, H. (2015). MRI of rectal cancer: an overview and update on recent advances. Am. J. Roentgenol. 205: W42–W55.

48 48 Patel, U.B., Blomqvist, L.K., Taylor, F. et al. (2012). MRI after treatment of locally advanced rectal cancer: how to report tumor response – the MERCURY experience. Am. J. Roentgenol. 199: W486–W495.

49 49 Vliegen, R.F., Beets, G.L., Lammering, G. et al. (2008). Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 246: 454–462.

50 50 Chen, C.C., Lee, R.C., Lin, J.K. et al. (2005). How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis. Colon Rectum 48: 722–728.

51 51 Kuo, L.J., Chern, M.C., Tsou, M.H. et al. (2005). Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis. Colon Rectum 48: 23–28.

52 52 Muthusamy, V.R. and Chang, K.J. (2007). Optimal methods for staging rectal cancer. Clin. Cancer Res. 13: 6877s–6884s.

53 53 Allen, S.D., Padhani, A.R., Dzik‐Jurasz, A.S., and Glynne‐Jones, R. (2007). Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. Am. J. Roentgenol. 188: 442–451.

54 54 Maretto, I., Pomerri, F., Pucciarelli, S. et al. (2007). The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann. Surg. Oncol. 14: 455–461.

55 55 Del Vescovo, R., Trodella, L.E., Sansoni, I. et al. (2012). MR imaging of rectal cancer before and after chemoradiation therapy. Radiol. Med. 117: 1125–1138.

56 56 Gagliardi, G., Hawley, P.R., Hershman, M.J., and Arnott, S.J. (1995). Prognostic factors in surgery for local recurrence of rectal cancer. Br. J. Surg. 82: 1401–1405.

57 57 Potter, K.C., Husband, J.E., Houghton, S.L. et al. (2009). Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis. Colon Rectum 52: 253–259.

58 58 Sammour, T. and Skibber, J.M. (2018). Evaluation of treatment of locally recurrent rectal cancer. In: Rectal Cancer: Modern Approaches to Treatment (ed. G.J. Chang), 231–245. Cham: Springer International Publishing.

59 59 Watson, A.J., Lolohea, S., Robertson, G.M., and Frizelle, F.A. (2007). The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis. Colon Rectum 50: 102–114.

60 60 Selvaggi, F., Fucini, C., Pellino, G. et al. (2015). Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients. Tech. Coloproctol. 19: 135–144.

61 61 Floriani, I., Torri, V., Rulli, E. et al. (2010). Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta‐analysis. J. Magn. Reson. Imaging 31: 19–31.

62 62 Bellomi, M., Rizzo, S., Travaini, L.L. et al. (2007). Role of multidetector CT and FDG‐PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer. Radiol. Med. 112: 681–690.

63 63 Agarwal, A., Marcus, C., Xiao, J. et al. (2014). FDG PET/CT in the management of colorectal and anal cancers. Am. J. Roentgenol. 203: 1109–1119.

64 64 Zhang, C., Chen, Y., Xue, H. et al. (2009). Diagnostic value of FDG‐PET in recurrent colorectal carcinoma: a meta‐analysis. Int. J. Cancer 124: 167–173.

65 65 Sugarbaker, P.H. and Jablonski, K.A. (1995). Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann. Surg. 221: 124–132.

66 66 Portilla, A.G., Sugarbaker, P.H., and Chang, D. (1999). Second‐look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J. Surg. 23: 23–29.

67 67 Sugarbaker, P.H. (1999). Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother. Pharmacol. 43: S15–S25.

68 68 Elias, D., Blot, F., El Otmany, A. et al. (2001). Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92: 71–76.

69 69 Glehen, O. and Gilly, F.N. (2003). Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg. Oncol. Clin. North Am. 12: 649–671.

70 70 Tentes, A.A., Tripsiannis, G., Markakidis, S.K. et al. (2003). Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur. J. Surg. Oncol. 29: 69–73.

71 71 Harmon, R.L. and Sugarbaker, P.H. (2005). Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int. Semin. Surg. Oncol. 2: 3.

72 72 Low, R.N., Barone, R.M., and Lucero, J. (2015). Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann. Surg. Oncol. 22: 1708–1715.

73 73 Koh, J.L., Yan, T.D., Glenn, D., and Morris, D.L. (2009). Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann. Surg. Oncol. 16: 327–333.

74 74 Chua, T.C., Al‐Zahrani, A., Saxena, A. et al. (2011). Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann. Surg. Oncol. 18: 1582–1589.

75 75 Fujii, S., Matsusue, E., Kanasaki, Y. et al. (2008). Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion‐weighted MR imaging. Eur. Radiol. 18: 18–23.